| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 3/6 |
Invesco Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$268.00 |
| 52 Week High | US$278.00 |
| 52 Week Low | US$260.00 |
| Beta | 1.42 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -3.60% |
Recent News & Updates
Recent updates
Shareholder Returns
| IVZ N | MX Capital Markets | MX Market | |
|---|---|---|---|
| 7D | 0% | -0.4% | 2.4% |
| 1Y | n/a | 0.7% | 2.6% |
Return vs Industry: Insufficient data to determine how IVZ N performed against the MX Capital Markets industry.
Return vs Market: Insufficient data to determine how IVZ N performed against the MX Market.
Price Volatility
| IVZ N volatility | |
|---|---|
| IVZ N Average Weekly Movement | n/a |
| Capital Markets Industry Average Movement | 4.0% |
| Market Average Movement | 3.8% |
| 10% most volatile stocks in MX Market | 6.1% |
| 10% least volatile stocks in MX Market | 1.9% |
Stable Share Price: IVZ N has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine IVZ N's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1935 | 8,527 | Andrew Schlossberg | www.invesco.com |
Invesco Ltd. is a publicly owned investment manager. The firm provides its services to retail clients, institutional clients, high-net worth clients, public entities, corporations, unions, non-profit organizations, endowments, foundations, pension funds, financial institutions, and sovereign wealth funds. It manages separate client-focused equity and fixed income portfolios.
Invesco Ltd. Fundamentals Summary
| IVZ N fundamental statistics | |
|---|---|
| Market cap | Mex$113.14b |
| Earnings (TTM) | -Mex$5.78b |
| Revenue (TTM) | Mex$99.00b |
1.1x
P/S Ratio-19.6x
P/E RatioIs IVZ N overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| IVZ N income statement (TTM) | |
|---|---|
| Revenue | US$5.77b |
| Cost of Revenue | US$4.32b |
| Gross Profit | US$1.45b |
| Other Expenses | US$1.79b |
| Earnings | -US$337.20m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.75 |
| Gross Margin | 25.13% |
| Net Profit Margin | -5.84% |
| Debt/Equity Ratio | 7.9% |
How did IVZ N perform over the long term?
See historical performance and comparisonDividends
5.6%
Current Dividend Yield-108%
Payout RatioDoes IVZ N pay a reliable dividends?
See IVZ N dividend history and benchmarks| Invesco dividend dates | |
|---|---|
| Ex Dividend Date | May 13 2024 |
| Dividend Pay Date | Jun 04 2024 |
| Days until Ex dividend | 15 days |
| Days until Dividend pay date | 37 days |
Does IVZ N pay a reliable dividends?
See IVZ N dividend history and benchmarks